Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GMED · against 145 other Healthcare companies of similar size
Ranked #30 of 146 · scores higher than 80% of peers
Bars: peers in each 10-point band of the growth score21 peers with a growth score of 80–89, including GMED · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
| Metric | GMED | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 147 reported | 19.7% | 10.2% | 72% | 33% | |
| Earnings per share growthHigher is better · 107 reported | 51.0% | 13.3% | 73% | 33% | |
| 3-year revenue growthHigher is better · 141 reported | 42.1% | 10.9% | 89% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 8.8B USD | 99 | 31 | |
| 2 | 9.3B USD | 98 | 64 | |
| 3 | 14.87T KRW (≈$10.7B) | 97 | 76 | |
| 3 | 7.3B USD | 97 | 74 | |
| 5 | 16.5B USD | 96 | 37 | |
| 24 | 20.0B AUD (≈$13.2B) | 87 | 77 | |
| 24 | 10.4B USD | 87 | 70 | |
| 28 | 936.1B JPY (≈$6.4B) | 86 | 80 | |
| 28 | 14.4B USD | 86 | 71 | |
| 30 | 10.7B USD | 85 | 78 | |
| 31 | 10.7B USD | 84 | 65 | |
| 32 | 1.26T INR (≈$15.1B) | 83 | 63 | |
| 32 | 9.1B USD | 83 | 74 | |
| 34 | 6.2B USD | 82 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score